Xanthos, Dimitris N <br/><br/>
The roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammation.  [electronic resource] 

 -  Neuropharmacology  Mar 2009 
 - 684-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2008.12.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--pharmacology<br/>Animals<br/>Central Nervous System Diseases--chemically induced<br/>Cholecystokinin--drug effects<br/>Disease Models, Animal<br/>Inflammation--chemically induced<br/>Injections, Spinal<br/>Lipopolysaccharides--administration & dosage<br/>Male<br/>Morphine--agonists<br/>Nerve Growth Factor--pharmacology<br/>Rats<br/>Rats, Long-Evans<br/>Sincalide--analogs & derivatives<br/>Spinal Cord--metabolism